WC
CDNA icon

Wexford Capital’s CareDx CDNA Stock Holding History

Wexford Capital’s Portfolio CDNA Stock Details CDNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-4,374
Closed -$77.6K – 259
2025
Q1 		$77.6K Buy
+4,374
New +$94.2K 0.02% 209
2018
Q2 		– Sell
-200,000
Closed -$1.59M – 118
2018
Q1 		$1.59M Hold
200,000
– – 0.12% 64
2017
Q4 		$1.47M Buy
+200,000
New +$1.25M 0.13% 78

Other funds holding CDNA

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $9.98B AUM 145.42% 1-Year Est. Return
GS
Gagnon Securities New York $433M AUM 29.08% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
OAM
Ophir Asset Management Sydney, Australia $859M AUM 59.08% 1-Year Est. Return

Wexford Capital's CDNA Position: Q2 2025 in Review

Wexford Capital sold out of CareDx (CDNA) in Q2 2025, closing a stake of 4,374 shares — an estimated $77.6K sold.

Wexford Capital first reported a position in CDNA in Q4 2017 and held it in 3 quarters. The position peaked at $1.59M in Q1 2018. 197 funds tracked by Wall St. Rank hold CDNA as of Q2 2025.

  • Wexford Capital reported no remaining CareDx position as of Q2 2025 after selling out during the quarter.
  • Wexford Capital sold 4,374 CareDx shares in Q2 2025, an estimated $77.6K.
  • Wexford Capital first reported a position in CareDx in Q4 2017 and held it in 3 quarters.
  • Wexford Capital's CareDx position peaked at $1.59M in Q1 2018.
  • 197 funds tracked by Wall St. Rank held CareDx as of Q2 2025.

Based on Wexford Capital's 13F filing for Q2 2025, filed 14 Aug 2025.